Tat Protein Induces Human Immunodeficiency Virus Type 1 (HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains

ABSTRACT Chemokine receptors CCR5 and CXCR4 are the primary fusion coreceptors utilized for CD4-mediated entry by macrophage (M)- and T-cell line (T)-tropic human immunodeficiency virus type 1 (HIV-1) strains, respectively. Here we demonstrate that HIV-1 Tat protein, a potent viral transactivator shown to be released as a soluble protein by infected cells, differentially induced CXCR4 and CCR5 expression in peripheral blood mononuclear cells. CCR3, a less frequently used coreceptor for certain M-tropic strains, was also induced. CXCR4 was induced on both lymphocytes and monocytes/macrophages, whereas CCR5 and CCR3 were induced on monocytes/macrophages but not on lymphocytes. The pattern of chemokine receptor induction by Tat was distinct from that by phytohemagglutinin. Moreover, Tat-induced CXCR4 and CCR5 expression was dose dependent. Monocytes/macrophages were more susceptible to Tat-mediated induction of CXCR4 and CCR5 than lymphocytes, and CCR5 was more readily induced than CXCR4. The concentrations of Tat effective in inducing CXCR4 and CCR5 expression were within the picomolar range and close to the range of extracellular Tat observed in sera from HIV-1-infected individuals. The induction of CCR5 and CXCR4 expression correlated with Tat-enhanced infectivity of M- and T-tropic viruses, respectively. Taken together, our results define a novel role for Tat in HIV-1 pathogenesis that promotes the infectivity of both M- and T-tropic HIV-1 strains in primary human leukocytes, notably in monocytes/macrophages.

[1]  C. Broder,et al.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. , 1996, Science.

[2]  G. Joø,et al.  Macrophage tropism: fact or fiction? , 1997, Journal of leukocyte biology.

[3]  G. Riethmüller,et al.  LOSS OF CIRCULATING T4+ MONOCYTES IN PATIENTS INFECTED WITH HTLV-III , 1986, The Lancet.

[4]  M. Previati,et al.  Exogenous human immunodeficiency virus type‐1 Tat protein selectively stimulates a phosphatidylinositol‐specific phospholipase C nuclear pathway in the Jurkat T cell line , 1995, European journal of immunology.

[5]  M. Negrini,et al.  The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. , 1995, Blood.

[6]  Hassan Mohammad Naif,et al.  CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.

[7]  Anthony S. Fauci,et al.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.

[8]  R. Gentz,et al.  Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[10]  A. Sica,et al.  Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes , 1997, The Journal of experimental medicine.

[11]  B. Chesebro,et al.  Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[12]  I. Hewlett,et al.  HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. , 1996, Journal of immunology.

[13]  Nancy Sullivan,et al.  CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.

[14]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[15]  K. Yamada,et al.  Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. , 1997, Journal of immunology.

[16]  C. Van Lint,et al.  Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway , 1997, Science.

[17]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[18]  A. Pardee,et al.  Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[20]  I. Hewlett,et al.  HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. , 1996, Journal of immunology.

[21]  J. Moore,et al.  Chemoattractants attract HIV researchers , 1996, The Journal of experimental medicine.

[22]  A. Trkola,et al.  Co-receptors for HIV-1 entry. , 1997, Current opinion in immunology.

[23]  R. Doms,et al.  A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains , 1996, Journal of virology.

[24]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[25]  K. Jones,et al.  Tat and the HIV-1 promoter. , 1993, Current opinion in cell biology.

[26]  M. Baggiolini,et al.  Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.

[27]  S. Capitani,et al.  Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. , 1996, Journal of immunology.

[28]  P. Wingfield,et al.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.

[29]  J. Skowroński,et al.  CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Pardee,et al.  Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Krammer,et al.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.

[32]  E. Engleman,et al.  Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. , 1989, Journal of immunology.

[33]  Ashley T. Haase,et al.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.

[34]  C. Mackay,et al.  Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes , 1998, The Journal of experimental medicine.

[35]  V. Karsten,et al.  HIV‐1 envelope glycoprotein gp120 down‐regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor‐α , 1996, Immunology.

[36]  B. Levine,et al.  Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. , 1997, Science.

[37]  Marc Parmentier,et al.  A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.

[38]  D. Mosier,et al.  Macrophage-tropic HIV: critical for AIDS pathogenesis? , 1994, Immunology today.

[39]  C. Ambrosino,et al.  The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein , 1994, The Journal of experimental medicine.

[40]  J. Zack,et al.  CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus , 1997, Journal of virology.

[41]  J. Sodroski,et al.  Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants , 1990, Journal of virology.

[42]  J. McCune Viral latency in HIV disease , 1995, Cell.

[43]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[44]  V. Metelev,et al.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.

[45]  C. Debouck,et al.  Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat , 1990, The Journal of cell biology.

[46]  R. Gallo,et al.  The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Frankel,et al.  Endocytosis and targeting of exogenous HIV‐1 Tat protein. , 1991, The EMBO journal.

[48]  L. Montaner,et al.  Lipopolysaccharide (LPS) down‐regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL‐1β , 1995, Clinical and experimental immunology.

[49]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[50]  M. Baggiolini,et al.  CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.

[51]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[52]  H. Sheppard,et al.  The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression , 1997, Nature Medicine.

[53]  T. Luger,et al.  Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. , 1997, Journal of immunology.

[54]  Luigi Buonaguro,et al.  HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region , 1997, AIDS.

[55]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[56]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[57]  L. Buonaguro,et al.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines , 1992, Journal of virology.

[58]  R. Doms,et al.  Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses , 1997, Journal of virology.

[59]  C. Mackay,et al.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Steven M. Wolinsky,et al.  The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.

[61]  P. Krammer,et al.  Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells , 1994, Journal of virology.

[62]  S. Krane,et al.  Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes. , 1983, Journal of immunology.

[63]  S. Capitani,et al.  An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[64]  M. Lenburg,et al.  Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4 , 1993, Journal of virology.